Afatinib Plus Bevacizumab Treatment for a Patient With EGFR S645C–Mutant Non–Small Cell Lung Cancer: A Case Report-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Afatinib Plus Bevacizumab Treatment for a Patient With EGFR S645C–Mutant Non–Small Cell Lung Cancer: A Case Report

Published:2024-06 Issue:8 Volume: Page:
ISSN:2473-4284
Container-title:JCO Precision Oncology
language:en
Short-container-title:JCO Precis Oncol

Author:

Shen Chia-I¹²³,Chang Ju-Chen⁴,Jain Suyog⁵,Olsen Steve⁵,Wu Chiao-En⁶^ORCID

Affiliation:

1. Department of Chest Medicine, Taipei Veterans General Hospital, Taipei, Taiwan

2. School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan

3. Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan

4. Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine, Taoyuan, Taiwan

5. Medical Affairs, Guardant Health AMEA, Singapore

6. Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine, Taoyuan, Taiwan

Publisher

American Society of Clinical Oncology (ASCO)

Link

https://ascopubs.org/doi/pdfdirect/10.1200/PO.24.00007

Reference25 articles.

1. NCCN Guidelines® Insights: Non–Small Cell Lung Cancer, Version 2.2023

2. Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations

3. Lung Cancer in Republic of China

4. Risk Stratification Using a Novel Nomogram for 2190 EGFR-Mutant NSCLC Patients Receiving the First or Second Generation EGFR-TKI

5. Epidermal growth factor receptor tyrosine kinase inhibitors for non‐small cell lung cancer harboring uncommon EGFR mutations: Real‐world data from Taiwan

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP